COLLARx technology produces a lyophilized porous matrix of purified collagen.
This proprietary collagen-based technology platform allows us to control the drug elution dynamics, texture, consistency, resorption time, and other physical characteristics of the finished product.
COLLARx technology is the foundation of our lead product, XARACOLL® (bupivacaine HCl) implant.
COLLAFILM technology produces a thin membrane of purified collagen ~50 microns in thickness.
The proprietary collagen-based technology platform creates a transparent, bioresorbable, and highly stable film.
The COLLAFILM technology is the foundation of our ex-US product, CollaGUARD Surgical Adhesion Barrier.